Immunocore Holdings plc
IMCR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001671927
No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Immunocore Holdings plc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 134
- +18 vs. Q1 2025
- Shares held
- 47.8M
- +494.7K (+1.0%) vs. Q1 2025
- Total value
- $1.50B
- +$96.4M (+6.9%) vs. Q1 2025
- New holders
- 31
- 45 more added
- Sold out
- 13
- 41 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $1.65B |
| Q1 2026 | 142 | $1.58B |
| Q4 2025 | 149 | $1.79B |
| Q3 2025 | 133 | $1.79B |
| Q2 2025 | 134 | $1.50B |
| Q1 2025 | 117 | $1.40B |
| Q4 2024 | 116 | $1.34B |
| Q3 2024 | 130 | $1.41B |
| Q2 2024 | 139 | $1.46B |
| Q1 2024 | 149 | $2.68B |
| Q4 2023 | 133 | $2.56B |
| Q3 2023 | 125 | $1.92B |
| Q2 2023 | 120 | $2.12B |
| Q1 2023 | 109 | $1.61B |
| Q4 2022 | 104 | $1.73B |
| Q3 2022 | 86 | $1.25B |
| Q2 2022 | 66 | $784.5M |
| Q1 2022 | 57 | $590.1M |
| Q4 2021 | 49 | $642.4M |
| Q3 2021 | 47 | $617.4M |
| Q2 2021 | 45 | $561.1M |
| Q1 2021 | 41 | $597.8M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Immunocore Holdings plc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caption Management, LLC | 179,503 | $5.63M | 0.52% | +150,110+510.7% | Added |
| Jane Street Group, LLC | 182,179 | $5.72M | 0.01% | +129,517+245.9% | Added |
| Bank of America Corp | 193,200 | $6.06M | 0.00% | −102,208−34.6% | Reduced |
| New York State Common Retirement Fund | 202,806 | $6.36M | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 204,217 | $6.41M | 0.01% | +150,581+280.7% | Added |
| BlackRock, Inc. | 221,379 | $6.95M | 0.00% | −4,166−1.8% | Reduced |
| Renaissance Technologies LLC | 222,052 | $6.97M | 0.01% | +131,482+145.2% | Added |
| Morgan Stanley | 237,879 | $7.46M | 0.00% | +64,018+36.8% | Added |
| Woodline Partners LP | 246,498 | $7.74M | 0.04% | −81,747−24.9% | Reduced |
| Millennium Management LLC | 276,502 | $8.68M | 0.01% | −8,768−3.1% | Reduced |
| TD Asset Management Inc | 286,264 | $8.98M | 0.01% | −9,590−3.2% | Reduced |
| Hudson Bay Capital Management LP | 345,952 | $10.9M | 0.07% | −49,382−12.5% | Reduced |
| Frazier Life Sciences Management, L.P. | 384,782 | $12.1M | 0.48% | +83,612+27.8% | Added |
| Two Sigma Investments, LP | 433,065 | $13.6M | 0.02% | +127,701+41.8% | Added |
| Massachusetts Financial Services Co | 445,767 | $14.0M | 0.00% | −14,984−3.3% | Reduced |
| Principal Financial Group Inc | 454,919 | $14.3M | 0.01% | −23,945−5.0% | Reduced |
| Two Sigma Advisers, LP | 512,430 | $16.1M | 0.03% | −10,970−2.1% | Reduced |
| Logos Global Management LP | 575,000 | $18.0M | 2.41% | +575,000 | New |
| Citigroup Inc | 634,501 | $19.9M | 0.01% | −4,787−0.7% | Reduced |
| Armistice Capital, LLC | 678,000 | $21.3M | 0.81% | −300,000−30.7% | Reduced |
| Fiera Capital Corp | 813,074 | $25.5M | 0.09% | +7,924+1.0% | Added |
| Point72 Asset Management, L.P. | 820,425 | $25.7M | 0.06% | +192,133+30.6% | Added |
| Kynam Capital Management, LP | 976,267 | $30.6M | 3.30% | −719,309−42.4% | Reduced |
| Price T Rowe Associates Inc | 1,005,592 | $31.6M | 0.00% | −882,348−46.7% | Reduced |
| BVF Inc | 1,024,288 | $32.1M | 1.15% | +1,024,288 | New |
| Deep Track Capital, LP | 1,800,000 | $56.5M | 1.82% | +388,598+27.5% | Added |
| Tang Capital Management LLC | 2,105,608 | $66.1M | 3.34% | +189,900+9.9% | Added |
| Baker Bros. Advisors LP | 2,322,656 | $72.9M | 0.71% | 00.0% | Unchanged |
| Bellevue Group AG | 2,441,830 | $76.6M | 1.69% | +1,220,036+99.9% | Added |
| Primecap Management Co | 3,771,474 | $118.3M | 0.09% | +1,092,824+40.8% | Added |
| Wellington Management Group LLP | 4,213,575 | $132.2M | 0.02% | −1,918,145−31.3% | Reduced |
| FMR LLC | 4,855,772 | $152.4M | 0.01% | +15,276+0.3% | Added |
| RTW Investments, LP | 4,869,798 | $152.8M | 2.18% | 00.0% | Unchanged |
| T. Rowe Price Investment Management, Inc. | 7,067,659 | $221.8M | 0.14% | +15,841+0.2% | Added |
| General Atlantic LLC | 0 | $0 | 0.00% | −1,261,684−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −110,101−100.0% | Sold out |
| Checkpoint Capital L.P. | 0 | $0 | 0.00% | −9,011−100.0% | Sold out |
| TD Waterhouse Canada Inc. | 0 | $0 | 0.00% | −7,411−100.0% | Sold out |
| Exchange Traded Concepts, LLC | 0 | $0 | 0.00% | −4,241−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −2,709−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,086−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −876−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −348−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −78−100.0% | Sold out |
| Continuum Advisory, LLC | 0 | $0 | 0.00% | −47−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Orion Portfolio Solutions, LLC | – | – | – | – | Not filed |